United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read General business news Aktion Associates acquires MNP’s Acumatica and Sage practices In a significant move to expand its presence in the North American market, Aktion Associates, Inc., a national… byPallavi MadhirajuMay 2, 2024